The Zhitong Finance App learned that Deshai-B (02526) rose more than 35% in the intraday period. As of press release, it had risen 30.15% to HK$640, with a turnover of HK$385.576 million.
According to the news, the Shanghai Stock Exchange issued a post-market notice on September 4. According to the relevant provisions of the “Shanghai Stock Exchange Shanghai-Hong Kong Stock Exchange Business Implementation Measures”, Deshit-B officially transferred to the Hong Kong Stock Exchange's securities list. The adjustment will take effect on September 7 (Monday). This means that mainland investors can now directly trade Deshi through the Shanghai-Shenzhen-Hong Kong Stock Connect, officially unlocking southbound capital.
Recently, Desch and the Hong Kong Polytechnic University officially inaugurated the “PolyU - Deshi Technology Joint Laboratory for General Artificial Intelligence and Medical Applications”. The two sides will carry out long-term research on medical imaging analysis, medical infrastructure model construction, and automation of medical R&D processes to promote the transformation of AIFor Science in the medical field between industry, education and research and development, and promote the linking of research results to the Mainland, Hong Kong and the global innovation network.
Earlier, the Zhitong Finance App was published in “How to choose an AI application for Hong Kong stocks? “Deshai-B (02526): A Scarce Target for Vertical AI with High Growth Rates and Strong Barriers” indicates that in vertical AI tracks, medical imaging AI is a high-quality segmented track with both short-term performance and long-term space. Unlike consumer-grade AI applications, medical AI faces the three core barriers of data compliance, clinical verification, and medical device supervision. It is difficult for new entrants to break through quickly by investing in computing power, and the competitive landscape of the industry is far superior to the general circuit. At the same time, with the improvement of medical insurance payment facilities and the release of demand on the hospital side, medical AI is moving from pilot demonstrations to large-scale implementation and entering a period of performance implementation. Deshai-B (02526) is a scarce target in the Hong Kong stock medical AI circuit, which perfectly fits the “high growth rate+strong barrier+clear catalytic” stock selection criteria.